Respiratory Health and Air Pollution
The impact of small particle air pollution on the lower airways (lungs) has long been studied, but now scientists have […]
Does Ivacaftor Affect Lung Bacteria in Cystic Fibrosis?
Ivacaftor has been shown to increase CFTR activity and lung function in people with Cystic Fibrosis and the G551D mutation, […]
Research on CF and Exercise in Cystic Fibrosis treatment
Significant research, both recent and decades old, shows that exercise helps people with CF. Yet it’s not always a part […]
Cystic Fibrosis Lung Microbiome: Diversity and Lung Function
The article, The Lung Microbiome and Airway Disease, published September 2016 in the Annals of the American Thoracic Society, describes […]
CFTR Function and Cigarette Smoke
Scientists are looking at how the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) potentiator, Ivacaftor, might be used in COPD, specifically […]
The Lung Microbiome and Dysbiosis
The “microbiome” is a hot topic in respiratory medicine, with researchers from diverse fields such as chronic obstructive pulmonary disease, […]
Webinar: Infection Prevention During Bronchoscopy
Laurence Muscarella Ph.D. and Atul Mehta M.D. A detailed webinar (71:30 minutes) can be viewed online. Highlights: The latest research […]
Copper in Hospitals to Limit Cross-Infection
The use of copper in hospital rooms, may reduce cross-infection, a common concern in cystic fibrosis centers. Using copper on […]
Distinguishing Relapse from Reinfection in MAC
MAC is a non-tuberculosis mycobacterium (NTM). It is found everywhere in the environment, and since the 1990s has been increasingly […]
A New Tool for Cystic Fibrosis Lung Monitoring
Ultrashort Echo-Time MRI has been shown in a recent study, published last week in the Annals of the American Thoracic […]